| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Finger Injuries | 9 | 2019 | 145 | 2.560 |
Why?
|
| Amputation, Traumatic | 6 | 2021 | 135 | 2.350 |
Why?
|
| Surgery, Plastic | 8 | 2023 | 652 | 2.260 |
Why?
|
| Glucosephosphate Dehydrogenase | 8 | 2014 | 209 | 1.660 |
Why?
|
| Emergency Service, Hospital | 29 | 2024 | 7871 | 1.420 |
Why?
|
| Microsurgery | 11 | 2021 | 798 | 1.330 |
Why?
|
| Congresses as Topic | 4 | 2019 | 811 | 1.320 |
Why?
|
| Skin Transplantation | 4 | 2018 | 1097 | 1.240 |
Why?
|
| Transplants | 2 | 2018 | 208 | 1.040 |
Why?
|
| Replantation | 5 | 2021 | 145 | 1.030 |
Why?
|
| Surgical Flaps | 9 | 2017 | 1678 | 1.000 |
Why?
|
| Patient Transfer | 3 | 2024 | 789 | 0.790 |
Why?
|
| Brain Ischemia | 6 | 2022 | 3002 | 0.790 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 9 | 2014 | 95 | 0.760 |
Why?
|
| Syncope | 5 | 2016 | 431 | 0.730 |
Why?
|
| Patient Discharge | 4 | 2022 | 3465 | 0.730 |
Why?
|
| Delayed Diagnosis | 1 | 2024 | 452 | 0.680 |
Why?
|
| Tobacco Use Cessation | 1 | 2021 | 100 | 0.670 |
Why?
|
| Reperfusion | 1 | 2019 | 268 | 0.610 |
Why?
|
| Transplantation, Heterotopic | 3 | 2011 | 175 | 0.600 |
Why?
|
| Nerve Regeneration | 8 | 2004 | 800 | 0.550 |
Why?
|
| Patients | 1 | 2023 | 908 | 0.520 |
Why?
|
| Emergency Medicine | 5 | 2018 | 1222 | 0.520 |
Why?
|
| Peripheral Nerves | 5 | 2009 | 491 | 0.520 |
Why?
|
| Nails | 1 | 2017 | 298 | 0.500 |
Why?
|
| Stroke | 10 | 2022 | 9748 | 0.480 |
Why?
|
| Thumb | 4 | 2014 | 232 | 0.470 |
Why?
|
| Disability Evaluation | 4 | 2021 | 1824 | 0.460 |
Why?
|
| Ganglion Cysts | 1 | 2014 | 27 | 0.460 |
Why?
|
| Stents | 6 | 2017 | 3191 | 0.450 |
Why?
|
| Radial Neuropathy | 1 | 2014 | 27 | 0.450 |
Why?
|
| Carpal Tunnel Syndrome | 2 | 2014 | 305 | 0.450 |
Why?
|
| Trigger Finger Disorder | 1 | 2014 | 53 | 0.440 |
Why?
|
| Veins | 8 | 2003 | 769 | 0.440 |
Why?
|
| Tissue Survival | 1 | 2013 | 120 | 0.430 |
Why?
|
| Efficiency | 4 | 2021 | 479 | 0.410 |
Why?
|
| Telemetry | 1 | 2014 | 201 | 0.410 |
Why?
|
| Bone Transplantation | 1 | 2017 | 920 | 0.410 |
Why?
|
| Nerve Compression Syndromes | 1 | 2014 | 159 | 0.400 |
Why?
|
| Motor Cortex | 1 | 2020 | 1004 | 0.400 |
Why?
|
| NADP | 1 | 2013 | 228 | 0.400 |
Why?
|
| Referral and Consultation | 2 | 2024 | 3617 | 0.390 |
Why?
|
| Hand | 5 | 2023 | 909 | 0.380 |
Why?
|
| Estradiol | 2 | 2013 | 1947 | 0.380 |
Why?
|
| Adipose Tissue | 3 | 2018 | 3315 | 0.380 |
Why?
|
| Lidocaine | 2 | 2014 | 545 | 0.380 |
Why?
|
| Thrombin | 1 | 2014 | 601 | 0.380 |
Why?
|
| Hemostatics | 1 | 2014 | 247 | 0.380 |
Why?
|
| Toe Joint | 1 | 2011 | 19 | 0.370 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2014 | 582 | 0.370 |
Why?
|
| Ear | 3 | 2006 | 172 | 0.360 |
Why?
|
| China | 6 | 2021 | 2383 | 0.350 |
Why?
|
| Troponin | 1 | 2014 | 532 | 0.350 |
Why?
|
| Motor Activity | 2 | 2020 | 2711 | 0.350 |
Why?
|
| Clinical Clerkship | 1 | 2016 | 568 | 0.340 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2020 | 1498 | 0.340 |
Why?
|
| Sciatic Nerve | 6 | 2004 | 624 | 0.330 |
Why?
|
| Graft Survival | 5 | 2018 | 3904 | 0.320 |
Why?
|
| Joints | 1 | 2011 | 321 | 0.320 |
Why?
|
| Educational Measurement | 1 | 2016 | 1260 | 0.320 |
Why?
|
| Germ Cells | 1 | 2013 | 646 | 0.320 |
Why?
|
| Ear, External | 4 | 1993 | 165 | 0.320 |
Why?
|
| Tissue Plasminogen Activator | 3 | 2021 | 1164 | 0.310 |
Why?
|
| Neuroma | 3 | 2000 | 137 | 0.300 |
Why?
|
| Humans | 105 | 2024 | 766117 | 0.300 |
Why?
|
| Patient Selection | 2 | 2020 | 4249 | 0.290 |
Why?
|
| Anesthetics, Local | 1 | 2014 | 1005 | 0.280 |
Why?
|
| Hydrogen Peroxide | 6 | 2013 | 740 | 0.270 |
Why?
|
| Hemin | 2 | 1997 | 51 | 0.270 |
Why?
|
| Efficiency, Organizational | 3 | 2021 | 695 | 0.270 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2013 | 883 | 0.260 |
Why?
|
| Erythrocyte Membrane | 4 | 1997 | 428 | 0.260 |
Why?
|
| Tissue Transplantation | 1 | 2006 | 128 | 0.250 |
Why?
|
| Patient Admission | 3 | 2023 | 1365 | 0.250 |
Why?
|
| Autophagy | 1 | 2013 | 1349 | 0.240 |
Why?
|
| Oxidative Stress | 2 | 2013 | 3140 | 0.240 |
Why?
|
| Transplantation, Autologous | 7 | 2011 | 2125 | 0.230 |
Why?
|
| Endarterectomy, Carotid | 3 | 2017 | 556 | 0.230 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2024 | 20700 | 0.230 |
Why?
|
| Image Cytometry | 1 | 2004 | 51 | 0.220 |
Why?
|
| Pain, Postoperative | 1 | 2014 | 1768 | 0.220 |
Why?
|
| Societies, Medical | 1 | 2016 | 3955 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2004 | 228 | 0.210 |
Why?
|
| Male | 60 | 2024 | 363935 | 0.210 |
Why?
|
| Hypertension | 2 | 2022 | 8616 | 0.200 |
Why?
|
| Schwann Cells | 1 | 2003 | 195 | 0.200 |
Why?
|
| Tendons | 4 | 2017 | 555 | 0.200 |
Why?
|
| Body Fluids | 1 | 2023 | 321 | 0.190 |
Why?
|
| Erythrocytes | 6 | 2001 | 2394 | 0.190 |
Why?
|
| France | 1 | 2023 | 495 | 0.190 |
Why?
|
| Retrospective Studies | 18 | 2024 | 81565 | 0.190 |
Why?
|
| Skin Aging | 1 | 2023 | 140 | 0.190 |
Why?
|
| Length of Stay | 4 | 2023 | 6490 | 0.190 |
Why?
|
| Echocardiography | 1 | 2014 | 5041 | 0.180 |
Why?
|
| Female | 48 | 2024 | 396233 | 0.180 |
Why?
|
| Ambulances | 1 | 2021 | 94 | 0.180 |
Why?
|
| Rats | 19 | 2006 | 23717 | 0.180 |
Why?
|
| Time Factors | 10 | 2024 | 40108 | 0.180 |
Why?
|
| Neutrophils | 1 | 2013 | 3771 | 0.180 |
Why?
|
| Mobile Health Units | 1 | 2021 | 91 | 0.170 |
Why?
|
| Angioplasty | 2 | 2013 | 353 | 0.170 |
Why?
|
| Internship and Residency | 5 | 2018 | 5946 | 0.170 |
Why?
|
| Amputation Stumps | 1 | 2000 | 38 | 0.170 |
Why?
|
| Axons | 4 | 2006 | 1677 | 0.170 |
Why?
|
| Erythrocyte Deformability | 3 | 1996 | 54 | 0.170 |
Why?
|
| Cerebral Hemorrhage | 2 | 2010 | 2649 | 0.170 |
Why?
|
| Peripheral Nervous System Diseases | 2 | 2004 | 713 | 0.170 |
Why?
|
| Nerve Degeneration | 1 | 2004 | 748 | 0.170 |
Why?
|
| Prone Position | 1 | 2020 | 202 | 0.170 |
Why?
|
| Electrophoresis, Capillary | 1 | 1999 | 63 | 0.160 |
Why?
|
| Skull | 2 | 2001 | 819 | 0.160 |
Why?
|
| Texas | 1 | 2020 | 409 | 0.160 |
Why?
|
| Aqueous Humor | 1 | 1999 | 152 | 0.160 |
Why?
|
| Uveitis, Anterior | 1 | 1999 | 103 | 0.160 |
Why?
|
| Physicians | 3 | 2023 | 4591 | 0.160 |
Why?
|
| Fingers | 3 | 1993 | 509 | 0.150 |
Why?
|
| Absorbable Implants | 1 | 2001 | 333 | 0.150 |
Why?
|
| Recovery of Function | 3 | 2020 | 2971 | 0.150 |
Why?
|
| Gynecomastia | 1 | 1999 | 87 | 0.150 |
Why?
|
| Ovary | 1 | 2003 | 961 | 0.150 |
Why?
|
| Lipid Peroxidation | 2 | 1997 | 275 | 0.150 |
Why?
|
| Ascorbic Acid | 2 | 1999 | 657 | 0.150 |
Why?
|
| Sulfhydryl Compounds | 2 | 1997 | 296 | 0.150 |
Why?
|
| Oximetry | 1 | 2021 | 461 | 0.150 |
Why?
|
| Bone Plates | 2 | 2001 | 468 | 0.150 |
Why?
|
| Patient Positioning | 1 | 2020 | 330 | 0.150 |
Why?
|
| Bone Regeneration | 1 | 2001 | 436 | 0.150 |
Why?
|
| Cyclosporine | 2 | 2006 | 777 | 0.140 |
Why?
|
| Plasminogen Activators | 1 | 1998 | 199 | 0.140 |
Why?
|
| Glutathione | 3 | 1997 | 589 | 0.140 |
Why?
|
| Superoxides | 1 | 1998 | 382 | 0.140 |
Why?
|
| Apoptosis | 1 | 2013 | 9508 | 0.140 |
Why?
|
| Skin | 3 | 2023 | 4482 | 0.140 |
Why?
|
| Splints | 1 | 2017 | 108 | 0.140 |
Why?
|
| Reactive Oxygen Species | 2 | 2013 | 2144 | 0.140 |
Why?
|
| Adult | 23 | 2024 | 223139 | 0.140 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 2013 | 822 | 0.130 |
Why?
|
| Chi-Square Distribution | 1 | 2023 | 3432 | 0.130 |
Why?
|
| Granulocytes | 1 | 1998 | 548 | 0.130 |
Why?
|
| Femoral Vein | 3 | 1988 | 156 | 0.130 |
Why?
|
| Prenatal Diagnosis | 1 | 2004 | 1271 | 0.130 |
Why?
|
| Middle Aged | 29 | 2024 | 223083 | 0.130 |
Why?
|
| Carotid Stenosis | 3 | 2013 | 857 | 0.130 |
Why?
|
| Lacerations | 1 | 2017 | 150 | 0.130 |
Why?
|
| Triage | 1 | 2023 | 994 | 0.130 |
Why?
|
| Academic Medical Centers | 2 | 2024 | 2782 | 0.130 |
Why?
|
| Aged | 23 | 2024 | 171219 | 0.130 |
Why?
|
| Medicine | 1 | 2024 | 944 | 0.130 |
Why?
|
| Treatment Outcome | 11 | 2020 | 65219 | 0.120 |
Why?
|
| Down Syndrome | 1 | 2004 | 915 | 0.120 |
Why?
|
| Burnout, Professional | 1 | 2024 | 710 | 0.120 |
Why?
|
| Radiodermatitis | 1 | 1995 | 58 | 0.120 |
Why?
|
| Oxyhemoglobins | 1 | 1996 | 213 | 0.120 |
Why?
|
| Guidelines as Topic | 1 | 2021 | 1394 | 0.120 |
Why?
|
| Prospective Studies | 13 | 2022 | 54812 | 0.120 |
Why?
|
| Hypersensitivity | 1 | 2024 | 1168 | 0.120 |
Why?
|
| Patient Care | 1 | 2020 | 630 | 0.120 |
Why?
|
| Vascular Patency | 1 | 1998 | 914 | 0.120 |
Why?
|
| Medication Reconciliation | 1 | 2016 | 153 | 0.110 |
Why?
|
| Alloxan | 1 | 1994 | 13 | 0.110 |
Why?
|
| Outpatients | 1 | 2022 | 1596 | 0.110 |
Why?
|
| Vascular Surgical Procedures | 2 | 1998 | 1506 | 0.110 |
Why?
|
| Information Systems | 1 | 2016 | 400 | 0.110 |
Why?
|
| Anastomosis, Surgical | 3 | 2009 | 992 | 0.110 |
Why?
|
| Synovial Cyst | 1 | 1994 | 33 | 0.110 |
Why?
|
| Tendon Injuries | 1 | 2017 | 329 | 0.110 |
Why?
|
| Onium Compounds | 1 | 2013 | 26 | 0.110 |
Why?
|
| Hemolysis | 1 | 1996 | 408 | 0.110 |
Why?
|
| Monitoring, Physiologic | 1 | 2021 | 1794 | 0.110 |
Why?
|
| Single-Blind Method | 2 | 2014 | 1588 | 0.110 |
Why?
|
| Wakefulness | 1 | 2020 | 1282 | 0.110 |
Why?
|
| Quality Assurance, Health Care | 1 | 2004 | 2171 | 0.110 |
Why?
|
| Soft Tissue Injuries | 1 | 1995 | 173 | 0.110 |
Why?
|
| Dinitrochlorobenzene | 1 | 1993 | 18 | 0.110 |
Why?
|
| Counseling | 1 | 2021 | 1553 | 0.110 |
Why?
|
| Wrist | 1 | 1995 | 230 | 0.110 |
Why?
|
| Fascia | 1 | 2014 | 143 | 0.110 |
Why?
|
| Follow-Up Studies | 7 | 2022 | 39243 | 0.110 |
Why?
|
| Uric Acid | 1 | 1999 | 809 | 0.110 |
Why?
|
| Animals | 29 | 2013 | 168800 | 0.100 |
Why?
|
| Martial Arts | 1 | 1993 | 29 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2006 | 8113 | 0.100 |
Why?
|
| Complement System Proteins | 1 | 1996 | 716 | 0.100 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2013 | 138 | 0.100 |
Why?
|
| Rats, Inbred Strains | 6 | 1991 | 2077 | 0.100 |
Why?
|
| Tibial Fractures | 1 | 1995 | 276 | 0.100 |
Why?
|
| Thrombectomy | 1 | 2016 | 676 | 0.090 |
Why?
|
| Feasibility Studies | 3 | 2017 | 5300 | 0.090 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2013 | 330 | 0.090 |
Why?
|
| Rats, Inbred Lew | 3 | 2003 | 1167 | 0.090 |
Why?
|
| Fibrinolytic Agents | 2 | 2022 | 2077 | 0.090 |
Why?
|
| Cell Movement | 1 | 2003 | 5196 | 0.090 |
Why?
|
| Perioperative Period | 1 | 2012 | 252 | 0.090 |
Why?
|
| alpha-Thalassemia | 2 | 2001 | 53 | 0.090 |
Why?
|
| Point-of-Care Systems | 1 | 2020 | 1218 | 0.090 |
Why?
|
| Hemoglobins | 2 | 2001 | 1531 | 0.090 |
Why?
|
| Reproducibility of Results | 3 | 2024 | 20137 | 0.090 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2016 | 789 | 0.090 |
Why?
|
| Evidence-Based Practice | 1 | 2015 | 499 | 0.090 |
Why?
|
| Laser Therapy | 1 | 1998 | 1108 | 0.090 |
Why?
|
| Finger Joint | 1 | 2011 | 107 | 0.090 |
Why?
|
| Intensive Care Units | 2 | 2020 | 3798 | 0.090 |
Why?
|
| Breast | 1 | 1999 | 1950 | 0.090 |
Why?
|
| Leg | 1 | 1995 | 1088 | 0.090 |
Why?
|
| Medication Errors | 1 | 2016 | 784 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 5 | 2004 | 6059 | 0.090 |
Why?
|
| Radiography, Thoracic | 1 | 2016 | 1319 | 0.080 |
Why?
|
| Nerve Transfer | 1 | 1991 | 137 | 0.080 |
Why?
|
| Muscles | 3 | 1991 | 1576 | 0.080 |
Why?
|
| Emergency Medical Services | 1 | 2021 | 1937 | 0.080 |
Why?
|
| Health Behavior | 1 | 2021 | 2649 | 0.080 |
Why?
|
| Aged, 80 and over | 10 | 2020 | 59515 | 0.080 |
Why?
|
| Nitric Oxide | 1 | 1998 | 2142 | 0.080 |
Why?
|
| Diagnostic Imaging | 1 | 2023 | 3530 | 0.080 |
Why?
|
| Point Mutation | 2 | 2001 | 1591 | 0.080 |
Why?
|
| Education, Medical, Graduate | 2 | 2018 | 2419 | 0.080 |
Why?
|
| Thoracic Injuries | 1 | 1992 | 288 | 0.080 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 2727 | 0.080 |
Why?
|
| Myocardial Infarction | 3 | 2017 | 11509 | 0.080 |
Why?
|
| Constriction, Pathologic | 1 | 2012 | 1102 | 0.080 |
Why?
|
| Sequence Alignment | 1 | 2013 | 2174 | 0.080 |
Why?
|
| Patient Participation | 1 | 2017 | 1447 | 0.080 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2019 | 1414 | 0.080 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2019 | 1378 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2013 | 1241 | 0.070 |
Why?
|
| Embryonic Development | 1 | 2013 | 719 | 0.070 |
Why?
|
| Heart Valve Diseases | 2 | 2014 | 1029 | 0.070 |
Why?
|
| Hospitalization | 3 | 2023 | 10811 | 0.070 |
Why?
|
| Carotid Arteries | 1 | 2012 | 932 | 0.070 |
Why?
|
| Syndactyly | 1 | 2008 | 75 | 0.070 |
Why?
|
| Observer Variation | 1 | 2014 | 2611 | 0.070 |
Why?
|
| Endophthalmitis | 1 | 2010 | 263 | 0.070 |
Why?
|
| Adenine | 1 | 2013 | 994 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2008 | 378 | 0.070 |
Why?
|
| DNA Damage | 2 | 2013 | 2463 | 0.070 |
Why?
|
| Hand Deformities, Congenital | 1 | 2008 | 175 | 0.070 |
Why?
|
| Medical Errors | 1 | 2015 | 1260 | 0.070 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 2 | 1997 | 45 | 0.070 |
Why?
|
| Glycine | 1 | 2010 | 671 | 0.070 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 1 | 2006 | 28 | 0.070 |
Why?
|
| Blood Pressure | 1 | 2022 | 8532 | 0.070 |
Why?
|
| Lung Transplantation | 1 | 1996 | 1310 | 0.070 |
Why?
|
| Molecular Sequence Data | 3 | 2013 | 17597 | 0.060 |
Why?
|
| Sciatic Neuropathy | 1 | 2006 | 76 | 0.060 |
Why?
|
| Fellowships and Scholarships | 1 | 2015 | 1134 | 0.060 |
Why?
|
| Orthopedics | 1 | 2015 | 901 | 0.060 |
Why?
|
| Postoperative Complications | 2 | 2019 | 15808 | 0.060 |
Why?
|
| Electronic Health Records | 3 | 2020 | 4863 | 0.060 |
Why?
|
| Geriatric Assessment | 1 | 2013 | 1422 | 0.060 |
Why?
|
| Suture Techniques | 2 | 1993 | 774 | 0.060 |
Why?
|
| Electrocardiography | 2 | 2018 | 6409 | 0.060 |
Why?
|
| Hydroxyl Radical | 2 | 1997 | 81 | 0.060 |
Why?
|
| Workflow | 2 | 2020 | 859 | 0.060 |
Why?
|
| Hair | 2 | 2023 | 509 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2020 | 9354 | 0.060 |
Why?
|
| Arm Injuries | 2 | 2000 | 156 | 0.060 |
Why?
|
| Curriculum | 1 | 2018 | 3784 | 0.060 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2014 | 2255 | 0.060 |
Why?
|
| Wounds and Injuries | 1 | 2017 | 2513 | 0.060 |
Why?
|
| Acute Disease | 2 | 2010 | 7237 | 0.060 |
Why?
|
| RNA Interference | 1 | 2013 | 2828 | 0.060 |
Why?
|
| Thoracic Nerves | 1 | 2004 | 20 | 0.060 |
Why?
|
| Clinical Competence | 2 | 2018 | 4859 | 0.060 |
Why?
|
| Iliac Vein | 1 | 2004 | 71 | 0.060 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 3424 | 0.060 |
Why?
|
| Taiwan | 4 | 2001 | 521 | 0.060 |
Why?
|
| Pain Measurement | 1 | 2014 | 3576 | 0.060 |
Why?
|
| Caenorhabditis elegans | 1 | 2013 | 1476 | 0.050 |
Why?
|
| Neurons, Afferent | 1 | 2006 | 498 | 0.050 |
Why?
|
| Graft Rejection | 2 | 1996 | 4504 | 0.050 |
Why?
|
| Dissection | 2 | 1999 | 298 | 0.050 |
Why?
|
| United States | 7 | 2021 | 72920 | 0.050 |
Why?
|
| Receptors, Interferon | 1 | 2004 | 114 | 0.050 |
Why?
|
| Chromosome Deletion | 1 | 2008 | 1384 | 0.050 |
Why?
|
| Estrus | 1 | 2003 | 70 | 0.050 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2004 | 113 | 0.050 |
Why?
|
| Risk Factors | 7 | 2019 | 74857 | 0.050 |
Why?
|
| Nerve Block | 1 | 1990 | 717 | 0.050 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2014 | 2136 | 0.050 |
Why?
|
| Transplantation, Isogeneic | 1 | 2003 | 250 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3111 | 0.050 |
Why?
|
| Prostheses and Implants | 1 | 2009 | 1273 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3233 | 0.050 |
Why?
|
| Blood Vessels | 1 | 2008 | 1113 | 0.050 |
Why?
|
| Cohort Studies | 3 | 2016 | 41684 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2013 | 2946 | 0.050 |
Why?
|
| Ovulation | 1 | 2003 | 181 | 0.050 |
Why?
|
| Transplantation, Homologous | 2 | 2006 | 4860 | 0.050 |
Why?
|
| Free Radicals | 3 | 1997 | 237 | 0.050 |
Why?
|
| Nociceptors | 1 | 2006 | 460 | 0.050 |
Why?
|
| Immunoenzyme Techniques | 2 | 2003 | 1695 | 0.050 |
Why?
|
| Oxidation-Reduction | 3 | 1997 | 2221 | 0.050 |
Why?
|
| Cadaver | 2 | 2017 | 1362 | 0.050 |
Why?
|
| Public Health | 1 | 2015 | 2681 | 0.050 |
Why?
|
| Kinetics | 3 | 1996 | 6273 | 0.050 |
Why?
|
| Reference Values | 2 | 1999 | 4909 | 0.050 |
Why?
|
| Amniotic Fluid | 1 | 2004 | 381 | 0.050 |
Why?
|
| Workload | 2 | 2018 | 849 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2013 | 2768 | 0.050 |
Why?
|
| Microsatellite Repeats | 1 | 2004 | 784 | 0.050 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 13400 | 0.050 |
Why?
|
| Esthetics | 1 | 2023 | 327 | 0.050 |
Why?
|
| Abnormalities, Multiple | 1 | 2008 | 1424 | 0.040 |
Why?
|
| Scalp | 1 | 1984 | 389 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 1999 | 5889 | 0.040 |
Why?
|
| Ovariectomy | 1 | 2003 | 612 | 0.040 |
Why?
|
| Globins | 1 | 2001 | 406 | 0.040 |
Why?
|
| Genetic Variation | 2 | 1996 | 6612 | 0.040 |
Why?
|
| Electron Spin Resonance Spectroscopy | 2 | 1997 | 158 | 0.040 |
Why?
|
| Time and Motion Studies | 1 | 2020 | 143 | 0.040 |
Why?
|
| Health Facility Environment | 1 | 2020 | 32 | 0.040 |
Why?
|
| Blotting, Southern | 1 | 2000 | 772 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 1995 | 4959 | 0.040 |
Why?
|
| Tissue Engineering | 1 | 2009 | 1857 | 0.040 |
Why?
|
| Nervous System Diseases | 1 | 2010 | 1657 | 0.040 |
Why?
|
| Osseointegration | 1 | 2001 | 269 | 0.040 |
Why?
|
| Iduronate Sulfatase | 1 | 1999 | 10 | 0.040 |
Why?
|
| Hospital Bed Capacity | 1 | 2020 | 200 | 0.040 |
Why?
|
| Femoral Artery | 2 | 1998 | 826 | 0.040 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 2000 | 184 | 0.040 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2001 | 287 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 2017 | 5836 | 0.040 |
Why?
|
| Hydroxylation | 2 | 1997 | 139 | 0.040 |
Why?
|
| Mercaptoethanol | 1 | 1997 | 61 | 0.040 |
Why?
|
| Genetic Markers | 1 | 2004 | 2603 | 0.040 |
Why?
|
| Salicylates | 2 | 1997 | 125 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2001 | 1494 | 0.030 |
Why?
|
| Substance-Related Disorders | 1 | 2013 | 4418 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 1998 | 512 | 0.030 |
Why?
|
| Prognosis | 4 | 2013 | 29912 | 0.030 |
Why?
|
| Spectrometry, Fluorescence | 2 | 1997 | 694 | 0.030 |
Why?
|
| Deferoxamine | 1 | 1997 | 154 | 0.030 |
Why?
|
| Palladium | 1 | 1997 | 67 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2010 | 12426 | 0.030 |
Why?
|
| Arteries | 2 | 1993 | 1121 | 0.030 |
Why?
|
| Hemoglobin E | 1 | 1996 | 6 | 0.030 |
Why?
|
| Monocrotaline | 1 | 1996 | 26 | 0.030 |
Why?
|
| Spinal Cord Injuries | 1 | 2004 | 929 | 0.030 |
Why?
|
| Neural Conduction | 3 | 1989 | 442 | 0.030 |
Why?
|
| Nerve Fibers | 1 | 1999 | 704 | 0.030 |
Why?
|
| Gene Deletion | 2 | 2000 | 2667 | 0.030 |
Why?
|
| Saponins | 1 | 1996 | 47 | 0.030 |
Why?
|
| Hemoglobin A | 1 | 1996 | 84 | 0.030 |
Why?
|
| Hospitals, Urban | 1 | 1998 | 494 | 0.030 |
Why?
|
| Sutures | 1 | 1998 | 283 | 0.030 |
Why?
|
| Rabbits | 2 | 2001 | 4730 | 0.030 |
Why?
|
| Algorithms | 1 | 2016 | 14066 | 0.030 |
Why?
|
| DNA | 2 | 2004 | 7193 | 0.030 |
Why?
|
| Waiting Lists | 1 | 2020 | 779 | 0.030 |
Why?
|
| Surgical Procedures, Operative | 2 | 1999 | 1931 | 0.030 |
Why?
|
| Nitric Oxide Synthase | 1 | 1998 | 911 | 0.030 |
Why?
|
| Hemoglobin, Sickle | 1 | 1996 | 113 | 0.030 |
Why?
|
| Platinum | 1 | 1997 | 219 | 0.030 |
Why?
|
| Logistic Models | 1 | 2010 | 13273 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2023 | 2353 | 0.030 |
Why?
|
| Tibial Arteries | 1 | 1995 | 60 | 0.030 |
Why?
|
| Aftercare | 1 | 2021 | 915 | 0.030 |
Why?
|
| Digoxin | 1 | 1996 | 246 | 0.030 |
Why?
|
| Growth Substances | 1 | 1996 | 758 | 0.030 |
Why?
|
| Incidence | 4 | 2013 | 21513 | 0.030 |
Why?
|
| Pyruvate Kinase | 1 | 1996 | 192 | 0.030 |
Why?
|
| Salicylic Acid | 1 | 1994 | 60 | 0.030 |
Why?
|
| Chickens | 1 | 1996 | 842 | 0.030 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1994 | 411 | 0.030 |
Why?
|
| Hand Injuries | 2 | 1990 | 239 | 0.030 |
Why?
|
| Rats, Inbred BN | 1 | 1993 | 229 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2006 | 4213 | 0.030 |
Why?
|
| Documentation | 1 | 2020 | 911 | 0.030 |
Why?
|
| Cardiac Output | 1 | 1996 | 838 | 0.030 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 1998 | 463 | 0.030 |
Why?
|
| Mental Disorders | 1 | 2013 | 6871 | 0.030 |
Why?
|
| Fetal Hemoglobin | 1 | 1996 | 346 | 0.030 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 1996 | 479 | 0.030 |
Why?
|
| Safety | 1 | 1998 | 1157 | 0.030 |
Why?
|
| Popliteal Artery | 1 | 1995 | 311 | 0.030 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2017 | 497 | 0.030 |
Why?
|
| Sensation | 1 | 1995 | 331 | 0.030 |
Why?
|
| Neural Pathways | 1 | 2004 | 3079 | 0.030 |
Why?
|
| Pulmonary Circulation | 1 | 1996 | 744 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 1998 | 2227 | 0.030 |
Why?
|
| Vitamin E | 1 | 1997 | 872 | 0.030 |
Why?
|
| Surface Properties | 1 | 1996 | 1152 | 0.030 |
Why?
|
| Work Schedule Tolerance | 1 | 2017 | 553 | 0.030 |
Why?
|
| Vascular Resistance | 1 | 1996 | 939 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 36548 | 0.030 |
Why?
|
| Pressure | 1 | 1996 | 1171 | 0.020 |
Why?
|
| Child | 4 | 2015 | 80573 | 0.020 |
Why?
|
| Muscle Denervation | 1 | 1991 | 60 | 0.020 |
Why?
|
| Wrist Joint | 1 | 1994 | 264 | 0.020 |
Why?
|
| Phospholipids | 1 | 1996 | 776 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 1998 | 1437 | 0.020 |
Why?
|
| Liposomes | 1 | 1996 | 786 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 1994 | 457 | 0.020 |
Why?
|
| Tibial Nerve | 1 | 1991 | 55 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2013 | 24276 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 1996 | 1886 | 0.020 |
Why?
|
| Sural Nerve | 1 | 1991 | 105 | 0.020 |
Why?
|
| Peroneal Nerve | 1 | 1991 | 80 | 0.020 |
Why?
|
| Diet, Reducing | 1 | 2015 | 487 | 0.020 |
Why?
|
| Neoplasms | 1 | 2020 | 22344 | 0.020 |
Why?
|
| Contrast Media | 2 | 2020 | 5330 | 0.020 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2004 | 2040 | 0.020 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2012 | 170 | 0.020 |
Why?
|
| Genetic Testing | 2 | 2001 | 3594 | 0.020 |
Why?
|
| Base Sequence | 2 | 1993 | 12405 | 0.020 |
Why?
|
| Asia, Southeastern | 2 | 2001 | 115 | 0.020 |
Why?
|
| Enzyme Inhibitors | 2 | 2006 | 3722 | 0.020 |
Why?
|
| Temperature | 1 | 1998 | 2227 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2017 | 1475 | 0.020 |
Why?
|
| Cold Temperature | 1 | 1995 | 794 | 0.020 |
Why?
|
| Cerebrovascular Disorders | 1 | 1998 | 1478 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 1998 | 2213 | 0.020 |
Why?
|
| Pandemics | 2 | 2020 | 8725 | 0.020 |
Why?
|
| Thigh | 1 | 1991 | 236 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1993 | 1724 | 0.020 |
Why?
|
| Scapula | 1 | 1992 | 175 | 0.020 |
Why?
|
| Injections, Intradermal | 1 | 1990 | 116 | 0.020 |
Why?
|
| Hospitals | 1 | 2023 | 3887 | 0.020 |
Why?
|
| Ear Cartilage | 1 | 1990 | 62 | 0.020 |
Why?
|
| Brachial Plexus | 1 | 1992 | 171 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1991 | 705 | 0.020 |
Why?
|
| Cattle | 1 | 1996 | 3801 | 0.020 |
Why?
|
| Continuity of Patient Care | 1 | 2017 | 1075 | 0.020 |
Why?
|
| Wound Healing | 1 | 2001 | 2795 | 0.020 |
Why?
|
| Metacarpophalangeal Joint | 1 | 1990 | 82 | 0.020 |
Why?
|
| Clavicle | 1 | 1992 | 224 | 0.020 |
Why?
|
| Muscular Diseases | 1 | 1994 | 551 | 0.020 |
Why?
|
| Cartilage | 1 | 1993 | 797 | 0.020 |
Why?
|
| Abdominal Muscles | 1 | 1990 | 172 | 0.020 |
Why?
|
| Behavior Therapy | 1 | 2015 | 886 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2021 | 9657 | 0.020 |
Why?
|
| Reoperation | 1 | 1999 | 4309 | 0.020 |
Why?
|
| Ticlopidine | 1 | 2013 | 730 | 0.020 |
Why?
|
| Program Development | 1 | 2015 | 1297 | 0.020 |
Why?
|
| Electrophysiology | 1 | 1991 | 1263 | 0.020 |
Why?
|
| Nerve Tissue | 1 | 1989 | 78 | 0.020 |
Why?
|
| Neurosurgical Procedures | 1 | 1999 | 2078 | 0.020 |
Why?
|
| Potassium | 1 | 1993 | 1312 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 1998 | 2419 | 0.020 |
Why?
|
| Boston | 1 | 2021 | 9335 | 0.020 |
Why?
|
| Ischemic Attack, Transient | 1 | 2013 | 871 | 0.020 |
Why?
|
| Morbidity | 1 | 2013 | 1753 | 0.020 |
Why?
|
| Mass Screening | 1 | 2004 | 5450 | 0.020 |
Why?
|
| Fungi | 1 | 2010 | 347 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2020 | 3477 | 0.020 |
Why?
|
| Eye Infections, Bacterial | 1 | 2010 | 239 | 0.020 |
Why?
|
| Vitrectomy | 1 | 2010 | 389 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2013 | 1470 | 0.020 |
Why?
|
| Disease Models, Animal | 3 | 2004 | 18321 | 0.020 |
Why?
|
| Cause of Death | 1 | 1998 | 3715 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2004 | 8924 | 0.020 |
Why?
|
| Mice | 2 | 2013 | 81839 | 0.020 |
Why?
|
| Australia | 1 | 2010 | 1260 | 0.020 |
Why?
|
| History, 21st Century | 1 | 2013 | 1574 | 0.020 |
Why?
|
| Thionucleotides | 1 | 2006 | 107 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 7843 | 0.020 |
Why?
|
| Inflammation | 1 | 2006 | 10860 | 0.020 |
Why?
|
| Freund's Adjuvant | 1 | 2006 | 145 | 0.020 |
Why?
|
| Prevalence | 2 | 2013 | 15827 | 0.020 |
Why?
|
| Nerve Growth Factors | 1 | 1989 | 564 | 0.020 |
Why?
|
| Pain | 2 | 1999 | 5090 | 0.020 |
Why?
|
| Exons | 1 | 1991 | 2393 | 0.020 |
Why?
|
| S100 Proteins | 1 | 2006 | 214 | 0.020 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2012 | 1429 | 0.020 |
Why?
|
| Fibrosis | 1 | 1993 | 2073 | 0.020 |
Why?
|
| Young Adult | 3 | 2020 | 59868 | 0.020 |
Why?
|
| Iothalamic Acid | 1 | 1985 | 18 | 0.020 |
Why?
|
| Angiocardiography | 1 | 1985 | 149 | 0.020 |
Why?
|
| Age Factors | 2 | 2013 | 18386 | 0.020 |
Why?
|
| Motivation | 1 | 2015 | 2019 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2001 | 9378 | 0.010 |
Why?
|
| Cyclic GMP | 1 | 2006 | 394 | 0.010 |
Why?
|
| History, 20th Century | 1 | 2013 | 2762 | 0.010 |
Why?
|
| Hypertension, Pulmonary | 1 | 1996 | 1604 | 0.010 |
Why?
|
| Inpatients | 1 | 2016 | 2566 | 0.010 |
Why?
|
| TRPV Cation Channels | 1 | 2006 | 242 | 0.010 |
Why?
|
| Pregnancy | 2 | 2004 | 30233 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 8525 | 0.010 |
Why?
|
| Cholinergic Fibers | 1 | 2004 | 68 | 0.010 |
Why?
|
| Heart Rate | 1 | 1996 | 4204 | 0.010 |
Why?
|
| Neurofilament Proteins | 1 | 2006 | 335 | 0.010 |
Why?
|
| Telemedicine | 1 | 2021 | 3108 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 15882 | 0.010 |
Why?
|
| Ganglia, Spinal | 1 | 2006 | 529 | 0.010 |
Why?
|
| Tissue Donors | 1 | 1993 | 2392 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2015 | 3209 | 0.010 |
Why?
|
| Communication | 1 | 2017 | 3909 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 1996 | 5531 | 0.010 |
Why?
|
| Calcium | 1 | 1996 | 5770 | 0.010 |
Why?
|
| Cell Count | 1 | 2006 | 1825 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1994 | 2327 | 0.010 |
Why?
|
| Telomere | 1 | 2008 | 941 | 0.010 |
Why?
|
| Aspirin | 1 | 2013 | 3135 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 6506 | 0.010 |
Why?
|
| Hindlimb | 1 | 2004 | 512 | 0.010 |
Why?
|
| Leg Ulcer | 1 | 1982 | 71 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2015 | 5340 | 0.010 |
Why?
|
| Digoxigenin | 1 | 2000 | 26 | 0.010 |
Why?
|
| Oxygen | 1 | 1993 | 4247 | 0.010 |
Why?
|
| Chorionic Villi Sampling | 1 | 2000 | 35 | 0.010 |
Why?
|
| Education, Medical | 1 | 2013 | 1744 | 0.010 |
Why?
|
| Erythrocyte Count | 1 | 2001 | 157 | 0.010 |
Why?
|
| Visual Acuity | 1 | 2010 | 2672 | 0.010 |
Why?
|
| Action Potentials | 1 | 1988 | 1834 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2004 | 1085 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2016 | 8062 | 0.010 |
Why?
|
| Protein Transport | 1 | 2006 | 1939 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2006 | 3584 | 0.010 |
Why?
|
| Recurrence | 1 | 2012 | 8494 | 0.010 |
Why?
|
| Fractures, Bone | 1 | 1992 | 2041 | 0.010 |
Why?
|
| Bacteria | 1 | 2010 | 2212 | 0.010 |
Why?
|
| Survival Rate | 1 | 2013 | 12827 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 12061 | 0.010 |
Why?
|
| Mucopolysaccharidosis II | 1 | 1999 | 26 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2004 | 1736 | 0.010 |
Why?
|
| Motor Neurons | 1 | 2004 | 871 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2006 | 5020 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1994 | 12976 | 0.010 |
Why?
|
| Multigene Family | 1 | 2001 | 1081 | 0.010 |
Why?
|
| Exercise | 1 | 2015 | 5939 | 0.010 |
Why?
|
| Radiography | 1 | 2008 | 6943 | 0.010 |
Why?
|
| Muscle Development | 1 | 1979 | 258 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 1994 | 11642 | 0.010 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1997 | 205 | 0.010 |
Why?
|
| DNA, Superhelical | 1 | 1997 | 52 | 0.010 |
Why?
|
| Spectrophotometry | 1 | 1997 | 291 | 0.010 |
Why?
|
| Facial Nerve | 1 | 1979 | 277 | 0.010 |
Why?
|
| Cardenolides | 1 | 1996 | 17 | 0.010 |
Why?
|
| Isoelectric Point | 1 | 1996 | 76 | 0.010 |
Why?
|
| Vagus Nerve | 1 | 1979 | 458 | 0.010 |
Why?
|
| Adolescent | 2 | 2016 | 88819 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 1993 | 7850 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2010 | 12529 | 0.010 |
Why?
|
| Spinal Cord | 1 | 2004 | 1811 | 0.010 |
Why?
|
| Heterozygote | 1 | 2001 | 2796 | 0.010 |
Why?
|
| Fracture Fixation, Internal | 1 | 1981 | 981 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1994 | 339 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1996 | 2161 | 0.010 |
Why?
|
| Signal Transduction | 1 | 1996 | 23605 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 11035 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1994 | 1079 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1996 | 1527 | 0.010 |
Why?
|
| Heart Failure | 1 | 2016 | 11837 | 0.010 |
Why?
|
| Plasmids | 1 | 1997 | 2267 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 4565 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 1994 | 697 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2001 | 4887 | 0.010 |
Why?
|
| Coronary Disease | 1 | 1985 | 5919 | 0.010 |
Why?
|
| Alleles | 1 | 2001 | 6892 | 0.010 |
Why?
|
| Isoenzymes | 1 | 1994 | 1688 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 1999 | 2590 | 0.010 |
Why?
|
| Brain | 1 | 1996 | 27177 | 0.000 |
Why?
|
| Iron | 1 | 1997 | 1811 | 0.000 |
Why?
|
| Sequence Analysis, DNA | 1 | 1999 | 4780 | 0.000 |
Why?
|
| Multiple Trauma | 1 | 1990 | 369 | 0.000 |
Why?
|
| Tumor Cells, Cultured | 1 | 1994 | 6102 | 0.000 |
Why?
|
| Infant | 1 | 2008 | 36427 | 0.000 |
Why?
|
| Swine | 1 | 1996 | 5986 | 0.000 |
Why?
|
| Diatrizoate | 1 | 1985 | 81 | 0.000 |
Why?
|
| Diatrizoate Meglumine | 1 | 1985 | 80 | 0.000 |
Why?
|
| Iopamidol | 1 | 1985 | 188 | 0.000 |
Why?
|
| Genotype | 1 | 1999 | 13028 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1999 | 12775 | 0.000 |
Why?
|
| Fibroblast Growth Factors | 1 | 1989 | 871 | 0.000 |
Why?
|
| Thorax | 1 | 1985 | 554 | 0.000 |
Why?
|
| Phenotype | 1 | 1999 | 16716 | 0.000 |
Why?
|
| Random Allocation | 1 | 1985 | 2395 | 0.000 |
Why?
|
| Cell Line | 1 | 1994 | 15546 | 0.000 |
Why?
|
| Cerebral Cortex | 1 | 1996 | 5758 | 0.000 |
Why?
|
| Drug Combinations | 1 | 1985 | 2076 | 0.000 |
Why?
|
| Bone Screws | 1 | 1981 | 533 | 0.000 |
Why?
|
| Hemodynamics | 1 | 1985 | 4188 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1985 | 8038 | 0.000 |
Why?
|